구조모아 (StructureMoa)항암 chemical structure spider web
방문타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | Dose Group 5 |
Overview Company | Beijing GoBroad Hospital |
Overview Modality | CGT |
Overview Target | Gastric |
Overview Indication | Gastric; Gastric / Gastroesophageal Junction Adenocarcinoma |
Overview Phase | PRECLINICAL |
Overview Status | RECRUITING |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
Toxicology Major finding | Maternal PPI therapy during lactation: pantoprazole levels in human milk and possible neonatal implications.. Proton pump inhibitors (PPIs) are widely used for acid-related disorders, but limited data exist regarding their excretion into human breast milk. This study aimed to quantify pantoprazole levels in plasma and breast milk of lactating women and to assess potential infant exposure. Sixteen … |
Clinical Safety signal | Maternal PPI therapy during lactation: pantoprazole levels in human milk and possible neonatal implications.. Proton pump inhibitors (PPIs) are widely used for acid-related disorders, but limited data exist regarding their excretion into human breast milk. This study aimed to quantify pantoprazole levels in plasma and breast milk of lactating women and to assess potential infant exposure. Sixteen … |
Clinical Result source | ClinicalTrials.gov NCT00894803 |
Clinical Program phase | PRECLINICAL |
Clinical Trial ref | NCT00894803 |
타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | Dose Group 5 |
Overview Company | Beijing GoBroad Hospital |
Overview Modality | CGT |
Overview Target | Gastric |
Overview Indication | Gastric; Gastric / Gastroesophageal Junction Adenocarcinoma |
Overview Phase | PRECLINICAL |
Overview Status | RECRUITING |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
Toxicology Major finding | Maternal PPI therapy during lactation: pantoprazole levels in human milk and possible neonatal implications.. Proton pump inhibitors (PPIs) are widely used for acid-related disorders, but limited data exist regarding their excretion into human breast milk. This study aimed to quantify pantoprazole levels in plasma and breast milk of lactating women and to assess potential infant exposure. Sixteen … |
Clinical Safety signal | Maternal PPI therapy during lactation: pantoprazole levels in human milk and possible neonatal implications.. Proton pump inhibitors (PPIs) are widely used for acid-related disorders, but limited data exist regarding their excretion into human breast milk. This study aimed to quantify pantoprazole levels in plasma and breast milk of lactating women and to assess potential infant exposure. Sixteen … |
Clinical Result source | ClinicalTrials.gov NCT00894803 |
Clinical Program phase | PRECLINICAL |
Clinical Trial ref | NCT00894803 |
추천 비교
추천 비교